Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions
Blood and Lymphatic Cancer: Targets and Therapy · 2018
DOI: 10.2147/blctt.s136447 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2018. Verfasst von Agnieszka Blum und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Mater Misericordiae University Hospital, Dublin, UK, agnieszkablum@mater.ie. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Mater Misericordiae University Hospital, Dublin, UK, agnieszkablum@mater.ie.
Zitieren
APA
Blum, A., Bazou, D., & O'Gorman, P. (2018). Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions. Blood and Lymphatic Cancer: Targets and Therapy. https://doi.org/10.2147/blctt.s136447
Vancouver
Blum A, Bazou D, O'Gorman P. Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions. Blood and Lymphatic Cancer: Targets and Therapy. 2018. doi:10.2147/blctt.s136447
BibTeX
@article{Blum2018,
author = {Blum, Agnieszka and Bazou, Despina and O'Gorman, Peter},
title = {Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions},
journal = {Blood and Lymphatic Cancer: Targets and Therapy},
year = {2018},
doi = {10.2147/blctt.s136447}
}
EUVIMED